Wealthcare Advisory Partners’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-500
Closed -$5K 2087
2021
Q1
$5K Buy
+500
New +$4.66K ﹤0.01% 1676
2020
Q2
Sell
-500
Closed -$4K 1496
2020
Q1
$4K Hold
500
﹤0.01% 1198
2019
Q4
$5K Hold
500
﹤0.01% 1122
2019
Q3
$5K Hold
500
﹤0.01% 1090
2019
Q2
$5K Hold
500
﹤0.01% 1079
2019
Q1
$5K Hold
500
﹤0.01% 984
2018
Q4
$4K Hold
500
﹤0.01% 1004
2018
Q3
$5K Buy
+500
New +$4.8K ﹤0.01% 1014

Other funds holding JHB

Wealthcare Advisory Partners's JHB Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Nuveen Corporate Income November 2021 Target Term Fund (JHB) in Q2 2021, closing a stake of 500 shares — an estimated $5K sold.

Wealthcare Advisory Partners first reported a position in JHB in Q3 2018 and held it in 8 quarters. The position peaked at $5K in Q1 2021. 57 funds tracked by Wall St. Rank hold JHB as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Nuveen Corporate Income November 2021 Target Term Fund position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 500 Nuveen Corporate Income November 2021 Target Term Fund shares in Q2 2021, an estimated $5K.
  • Wealthcare Advisory Partners first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q3 2018 and held it in 8 quarters.
  • Wealthcare Advisory Partners's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $5K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.